Once weekly tirzepatide significantly reduces body mass index in adolescents with obesity compared with placebo.
Rural patients with HFrEF had lower mortality when treated at urban hospitals but higher early mortality than urban patients ...
Building a third-line treatment framework starts with molecular profile and available targeted options, but ultimately rests ...
Most eligible patients stand to benefit from twice-yearly dosing, though candidate selection still matters, and clinical trial data reveal no new safety signals relative to more frequently dosed ...
With multiple oral JAK inhibitors approaching approval, sequencing decisions and adverse-event management are becoming urgent clinical questions. Dr. Desai and Dr. Hamzavi outline how they select ...
FDA approves dexmedetomidine sublingual film for at-home use in adults with schizophrenia, schizoaffective disorder, or bipolar I or II disorder.
Lead VERIFY trial investigator Andrew Kuykendall, MD, explains how rusfertide could replace phlebotomy and ease fatigue in ...
Inebilizumab cut MG exacerbations and rescue therapy use in MINT, and a post hoc analysis found similar responses regardless ...
Non-US-born adults had higher CRC screening nonadherence than US-born adults, particularly those with less than 15 years of US residence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results